Fil LTD Adagene Inc. Transaction History

Fil LTD

$96.6 Billion
Q1 2025

A detailed history of Fil LTD transactions in Adagene Inc. stock. As of the latest transaction made, Fil LTD holds 749,448 shares of ADAG stock, worth $1.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

749,448

Previous 3,274,798 77.11%

Holding current value

$1.31 Million

Previous $6.52 Million 82.52%

% of portfolio

0.0%

Previous 0.01%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$1.52 - $2.1 $3.84 Million - $5.3 Million	-2,525,350 Reduced 77.11%	749,448 $1.14 Million
Q4 2024 Feb 13, 2025	SELL	$1.88 - $3.15 $612,124 - $1.03 Million	-325,598 Reduced 9.04%	3,274,798 $6.52 Million
Q3 2024 Nov 13, 2024	SELL	$2.12 - $3.49 $479,128 - $788,753	-226,004 Reduced 5.91%	3,600,396 $7.99 Million
Q2 2024 Aug 13, 2024	SELL	$2.12 - $3.24 $39,084 - $59,732	-18,436 Reduced 0.48%	3,826,400 $11.7 Million
Q1 2024 May 13, 2024	BUY	$1.96 - $4.15 $7.54 Million - $16 Million	3,844,836 New	3,844,836 $10.8 Million

Others Institutions Holding ADAG

# of Institutions

Shares Held

10.4M

Call Options Held

Put Options Held

View Full List

About Adagene Inc.

Ticker ADAG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,423,200
Market Cap $76M
Description
Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company's product candidates include ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibodies (mAbs) that is in Phase 1b/2 clinical trials for the treatment advanced solid ...

More about ADAG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.

Account